Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Necrobiotic Xanthogranuloma

lenalidomide has been researched along with Necrobiotic Xanthogranuloma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Adam, Z; Adamová, Z; Boichuk, I; Dvořáková, K; Koukalová, R; Král, Z; Krejčí, M; Packová, B; Pour, L; Řehák, Z; Sandecká, V; Štork, M1
Nguyen, BD1
Chong, H; Mahendran, P; Natkunarajah, J; Wee, J1
Al Ustwani, O; Bhat, SA; Bogner, P; Ghani, S; Grassi, M; Khalid, B; Powell, J1
Cappel, M; Dholaria, BR; Roy, V1

Other Studies

5 other study(ies) available for lenalidomide and Necrobiotic Xanthogranuloma

ArticleYear
Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2022,Summer, Volume: 35, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bortezomib; Dexamethasone; Gilbert Disease; Humans; Hyperbilirubinemia; Lenalidomide; Multiple Myeloma; Necrobiotic Xanthogranuloma; Positron Emission Tomography Computed Tomography

2022
Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:10

    Topics: Dexamethasone; Drug Therapy, Combination; Female; Humans; Lenalidomide; Liver; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Necrobiotic Xanthogranuloma; Positron Emission Tomography Computed Tomography; Skin; Skin Diseases

2017
Necrobiotic xanthogranuloma treated with lenalidomide.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:3

    Topics: Aged; Angiogenesis Inhibitors; Dermatologic Agents; Female; Humans; Immunologic Factors; Lenalidomide; Necrobiotic Xanthogranuloma; Thalidomide

2018
Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
    Clinical advances in hematology & oncology : H&O, 2013, Volume: 11, Issue:10

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Dexamethasone; Female; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Necrobiotic Xanthogranuloma; Orbital Neoplasms; Thalidomide

2013
Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.
    Annals of hematology, 2016, Volume: 95, Issue:4

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Dexamethasone; Drug Therapy, Combination; Humans; Lenalidomide; Male; Middle Aged; Necrobiotic Xanthogranuloma; Paraproteinemias; Thalidomide; Treatment Outcome

2016